Promising Therapy Undergoing Clinical TrialsMedically reviewed by Lyndsey Garbi, MDMedically reviewed by Lyndsey Garbi, ...

A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...

Current sickle cell disease treatment options include: A cornerstone of SCD treatment since 1988, hydroxyurea works by increasing the production of hemoglobin F, which helps prevent the formation of ...

A Johns Hopkins analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in ...

Earlier this year, STAT’s Eric Boodman reported the heartbreaking story of how, for decades, doctors have pressured sickle ...

The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...

(Bloomberg) -- European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease complications in patients who started taking it.

SAFETY PROGRAM. TIME FOR FIVE ON YOUR HEALTH. WE’RE FOCUSING ON SICKLE CELL DISEASE. IT IS A PAINFUL, INHERITED CONDITION THAT PRIMARILY AFFECTS AFRICAN AMERICANS. HERE WITH SOME INSIGHT IS ...

Why Gene Therapy for Sickle Cell Is Slow to Catch on With Patients By Deena Beasley LOS ANGELES (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the ...

The European Union's drug watchdog on Thursday, September 26, 2024, called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, saying doctors should stop using the drug.

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...